Treatment outcomes following continuous miglustat therapy in patients with Niemann-Pick disease Type C: a final report of the NPC Registry

[1]  M. Patterson,et al.  Psychiatric and neurological symptoms in patients with Niemann-Pick disease type C (NP-C): Findings from the International NPC Registry , 2019, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[2]  M. Pineda,et al.  Disease characteristics, prognosis and miglustat treatment effects on disease progression in patients with Niemann-Pick disease Type C: an international, multicenter, retrospective chart review , 2019, Orphanet Journal of Rare Diseases.

[3]  C. Tilikete,et al.  Adult Niemann-Pick disease type C in France: clinical phenotypes and long-term miglustat treatment effect , 2018, Orphanet Journal of Rare Diseases.

[4]  M. Patterson,et al.  Miglustat in Niemann-Pick disease type C patients: a review , 2018, Orphanet Journal of Rare Diseases.

[5]  M. Patterson,et al.  Consensus clinical management guidelines for Niemann-Pick disease type C , 2018, Orphanet Journal of Rare Diseases.

[6]  P. Bauer,et al.  Recommendations for the detection and diagnosis of Niemann-Pick disease type C , 2017, Neurology. Clinical practice.

[7]  D. Galanaud,et al.  Normalisation of brain spectroscopy findings in Niemann–Pick disease type C patients treated with miglustat , 2016, Journal of Neurology.

[8]  J. Imrie,et al.  Observational cohort study of the natural history of Niemann-Pick disease type C in the UK: a 5-year update from the UK clinical database , 2015, BMC Neurology.

[9]  M. Patterson,et al.  Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-Pick disease type C: an observational cohort study , 2015, Orphanet Journal of Rare Diseases.

[10]  C. Ponting,et al.  High Incidence of Unrecognized Visceral/Neurological Late-onset Niemann-Pick Disease, type C1 Predicted by Analysis of Massively Parallel Sequencing Data Sets , 2015, Genetics in Medicine.

[11]  M. Hřebíček,et al.  Observational, retrospective study of a large cohort of patients with Niemann-Pick disease type C in the Czech Republic: a surprisingly stable diagnostic rate spanning almost 40 years , 2014, Orphanet Journal of Rare Diseases.

[12]  F. Sedel,et al.  Niemann-Pick type C Suspicion Index tool: analyses by age and association of manifestations , 2013, Journal of Inherited Metabolic Disease.

[13]  M. Patterson,et al.  Disease and patient characteristics in NP-C patients: findings from an international disease registry , 2013, Orphanet Journal of Rare Diseases.

[14]  F. Sedel,et al.  Recommendations for the diagnosis and management of Niemann-Pick disease type C: an update. , 2012, Molecular genetics and metabolism.

[15]  C. Hendriksz,et al.  Gastrointestinal disturbances and their management in miglustat-treated patients , 2011, Journal of Inherited Metabolic Disease.

[16]  R. Lachmann,et al.  Dietary modifications in patients receiving miglustat , 2010, Journal of Inherited Metabolic Disease.

[17]  M. Vanier Niemann-Pick disease type C , 2010, Orphanet journal of rare diseases.

[18]  M. Patterson,et al.  Miglustat in adult and juvenile patients with Niemann-Pick disease type C: long-term data from a clinical trial. , 2010, Molecular genetics and metabolism.

[19]  M. Patterson,et al.  Long-Term Miglustat Therapy in Children With Niemann-Pick Disease Type C , 2010, Journal of child neurology.

[20]  F. Sedel,et al.  Natural history of Niemann-Pick disease type C in a multicentre observational retrospective cohort study. , 2009, Molecular genetics and metabolism.

[21]  M. Baumgartner,et al.  Recommendations on the diagnosis and management of Niemann-Pick disease type C. , 2009, Molecular genetics and metabolism.

[22]  M. Patterson,et al.  Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study , 2007, The Lancet Neurology.

[23]  G. Francis,et al.  The National Niemann–Pick C1 disease database: Report of clinical features and health problems , 2007, American journal of medical genetics. Part A.

[24]  M. Pineda,et al.  Niemann–Pick C disease in Spain: Clinical spectrum and development of a disability scale , 2006, Journal of the Neurological Sciences.

[25]  S. Sherlock,et al.  Niemann-Pick disease type C: diagnosis and outcome in children, with particular reference to liver disease. , 1993, The Journal of pediatrics.

[26]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..